Asia Pacific Dietary Supplement Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type, By Dosage Form (Tablets, Capsules, Liquid Oral, Powder In Sachet/Jar, Gummies and Others. By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Dietary Supplement Contract Manufacturing Market would witness market growth of 13.1% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Dietary Supplement Contract Manufacturing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $10,985 million by 2031. The Japan market is registering a CAGR of 12.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 13.8% during (2024 - 2031).



Quality control technology innovations enhance product safety, purity, and consistency throughout the manufacturing process. Advanced analytical techniques like atomic absorption spectroscopy (AAS), gas chromatography-mass spectrometry (GC-MS), and high-performance liquid chromatography (HPLC) are being utilized by contract manufacturers to examine raw materials, intermediate products, and finished goods for contaminants, potency, and purity.

In addition, contract manufacturers work closely with brands and retailers to develop custom formulations that meet consumer preferences, market trends, and regulatory standards. Whether it's a private-label product, a custom blend, or a white-label solution, contract manufacturers provide turnkey solutions to bring dietary supplement products from concept to shelf-ready finished goods.

The Chinese government has prioritized sports development as part of its broader initiatives to promote public health and wellness. Efforts and policies directed towards augmenting sports engagement, constructing sports infrastructure, and organizing global sporting events stimulate the expansion of the sports industry and propel the demand for sports nutrition products. As per the data from the State Council of China, the country’s sports industry experienced substantial expansion in 2022, attaining a cumulative value of 3.3 trillion yuan ($461.3 billion), reflecting a year-on-year growth of 5.9 percent. Additionally, the pharmaceutical sector in India has undergone significant diversification in recent years, with many pharmaceutical companies expanding their portfolios to include dietary supplements and nutraceuticals. As per the data released in 2023 by the India Brand Equity Foundation, it is expected that the Indian pharmaceuticals sector will attain a value of US$65 billion by 2024 and US$130 billion by 2030. Hence, the growing pharmaceutical and sports sectors in Asia Pacific will drive the growth of the regional dietary supplement contract manufacturing market.

Based on Product Type, the market is segmented into Proteins & Amino Acid Supplements, Multivitamin, Multi-Mineral, & Antioxidant Supplements, Weight Management & Meal Replacer Supplements and Other Supplements. Based on Dosage Form, the market is segmented into Tablets, Capsules, Liquid Oral, Powder In Sachet/Jar, Gummies and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Ashland Inc.
• Lonza Group Ltd.
• Captek Softgel International, Inc.
• DCC Plc
• Glanbia PLC
• Catalent, Inc.
• Biotrex Nutraceuticals
• Martinez Nieto, S.A.
• Menadiona SL
• Nutrivo LLC

Market Report Segmentation

By Product Type

• Proteins & Amino Acid Supplements
• Multivitamin, Multi-Mineral, & Antioxidant Supplements
• Weight Management & Meal Replacer Supplements
• Other Supplements

By Dosage Form

• Tablets
• Capsules
• Liquid Oral
• Powder In Sachet/Jar
• Gummies
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific